131 related articles for article (PubMed ID: 17257358)
1. Clinical epidemiology of parathyroidectomy in hemodialysis patients: the USRDS waves 1, 3, and 4 study.
Slinin Y; Foley RN; Collins AJ
Hemodial Int; 2007 Jan; 11(1):62-71. PubMed ID: 17257358
[TBL] [Abstract][Full Text] [Related]
2. The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002.
Foley RN; Li S; Liu J; Gilbertson DT; Chen SC; Collins AJ
J Am Soc Nephrol; 2005 Jan; 16(1):210-8. PubMed ID: 15563573
[TBL] [Abstract][Full Text] [Related]
3. Fracture risk after parathyroidectomy among chronic hemodialysis patients.
Rudser KD; de Boer IH; Dooley A; Young B; Kestenbaum B
J Am Soc Nephrol; 2007 Aug; 18(8):2401-7. PubMed ID: 17634437
[TBL] [Abstract][Full Text] [Related]
4. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.
Danese MD; Kim J; Doan QV; Dylan M; Griffiths R; Chertow GM
Am J Kidney Dis; 2006 Jan; 47(1):149-56. PubMed ID: 16377396
[TBL] [Abstract][Full Text] [Related]
5. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study.
Slinin Y; Foley RN; Collins AJ
J Am Soc Nephrol; 2005 Jun; 16(6):1788-93. PubMed ID: 15814832
[TBL] [Abstract][Full Text] [Related]
6. Improvement of anemia after parathyroidectomy in Chinese patients with renal failure undergoing long-term dialysis.
Chow TL; Chan TT; Ho YW; Lam SH
Arch Surg; 2007 Jul; 142(7):644-8. PubMed ID: 17638802
[TBL] [Abstract][Full Text] [Related]
7. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
Block GA; Klassen PS; Lazarus JM; Ofsthun N; Lowrie EG; Chertow GM
J Am Soc Nephrol; 2004 Aug; 15(8):2208-18. PubMed ID: 15284307
[TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism.
Costa-Hong V; Jorgetti V; Gowdak LH; Moyses RM; Krieger EM; De Lima JJ
Surgery; 2007 Nov; 142(5):699-703. PubMed ID: 17981190
[TBL] [Abstract][Full Text] [Related]
10. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome following total parathyroidectomy in patients with end-stage renal disease.
Kaye M; Rosenthall L; Hill RO; Tabah RJ
Clin Nephrol; 1993 Apr; 39(4):192-7. PubMed ID: 8491048
[TBL] [Abstract][Full Text] [Related]
12. [Secondary hyperparathyroidism: incidence, clinical presentations, treatment].
Samokhvalova NA; Romanchishen AF; Gerasimchuk RP; Grinev KM; Zemchenkov AIu
Vestn Khir Im I I Grek; 2007; 166(5):78-81. PubMed ID: 18154100
[TBL] [Abstract][Full Text] [Related]
13. Parathyroidectomy improves the quality of sleep in maintenance hemodialysis patients with severe hyperparathyroidism.
Esposito MG; Cesare CM; De Santo RM; Cice G; Perna AF; Violetti E; Conzo G; Bilancio G; Celsi S; Annunziata F; Iannelli S; De Santo NG; Cirillo M; Livrea A
J Nephrol; 2008; 21 Suppl 13():S92-6. PubMed ID: 18446739
[TBL] [Abstract][Full Text] [Related]
14. Early identification of risk factors for refractory secondary hyperparathyroidism in patients with long-term renal replacement therapy.
Jorna FH; Tobé TJ; Huisman RM; de Jong PE; Plukker JT; Stegeman CA
Nephrol Dial Transplant; 2004 May; 19(5):1168-73. PubMed ID: 14993501
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of whole PTH assay and 1-84/non-(1-84) PTH ratio in patients on hemodialysis or undergoing parathyroidectomy.
Kato Y; Yamaguchi S; Yachiku S; Fujisawa M; Kawakami N
Hinyokika Kiyo; 2004 Nov; 50(11):755-62. PubMed ID: 15628534
[TBL] [Abstract][Full Text] [Related]
16. Influence of parathyroidectomy on mortality in hemodialysis patients: a prospective observational study.
Dussol B; Morand P; Martinat C; Lombard E; Portugal H; Brunet P; Berland Y
Ren Fail; 2007; 29(5):579-86. PubMed ID: 17654321
[TBL] [Abstract][Full Text] [Related]
17. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
[TBL] [Abstract][Full Text] [Related]
18. Ten years' experience in subtotal parathyroidectomy of hemodialysis patients.
Jovanovic DB; Pejanovic S; Vukovic L; Djukanovic L; Jankovic R; Kalezic N; Paunovic I; Zivaljevic V
Ren Fail; 2005; 27(1):19-24. PubMed ID: 15717630
[TBL] [Abstract][Full Text] [Related]
19. [Parathyroidectomy in end-stage renal disease: perioperative management of calcium-phosphorus balance].
Vallée M; Lalumière G; Déziel C; Quérin S; Madore F
Ann Biol Clin (Paris); 2007; 65(1):71-6. PubMed ID: 17264042
[TBL] [Abstract][Full Text] [Related]
20. Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access.
Lacson E; Wang W; Hakim RM; Teng M; Lazarus JM
Am J Kidney Dis; 2009 Jan; 53(1):79-90. PubMed ID: 18930570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
